Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Gastrointest Liver Physiol ; 302(8): G864-72, 2012 Apr 15.
Article in English | MEDLINE | ID: mdl-22301112

ABSTRACT

Beclin-1 has a central role in the regulation of autophagy. Barrett's esophagus (BE) is associated with a significantly increased risk for the development of esophageal adenocarcinoma (EAC). In the current study, we evaluated the role of Beclin-1 and autophagy in the EAC. Biopsies obtained from patients with BE and EAC, tissues from a rat model of BE and EAC, and esophageal cell lines were evaluated for the expression of Beclin-1 by immunohistochemistry, immunoblotting, or RT-PCR. Since reflux of bile acids is important in EAC, we also evaluated the effect of exposure to deoxycholic acid (DCA) on autophagy and Beclin-1 expression. Beclin-1 expression was high in squamous epithelium and nondysplastic BE, whereas its expression was low in dysplastic BE and EAC. The same pattern of expression was observed in rat tissues and in esophageal cell lines. Normal esophageal epithelium and HET-1A cells (derived from normal squamous epithelium) show high levels of Beclin-1, but lower levels of Beclin-1 were found in BE and EAC cell lines (CP-A, CP-C, and OE33). Acute exposure to DCA led to increased Beclin-1 expression and increased autophagy as evaluated by electron microscopy and counting percentage of GFP-LC3-positive BE cells with punctate pattern. In contrast, chronic exposure to DCA did not result in the alteration of Beclin-1 levels or autophagy. In summary, these data suggest that autophagy is initially activated in response to bile acids, but chronic exposure to bile acids leads to decreased Beclin-1 expression and autophagy resistance.


Subject(s)
Adenocarcinoma/pathology , Apoptosis Regulatory Proteins/biosynthesis , Apoptosis Regulatory Proteins/physiology , Deoxycholic Acid/physiology , Esophageal Neoplasms/pathology , Membrane Proteins/biosynthesis , Membrane Proteins/physiology , Amino Acids/deficiency , Animals , Autophagy , Barrett Esophagus/pathology , Beclin-1 , Bile Acids and Salts/metabolism , Blotting, Western , Cell Line, Tumor , Cell Proliferation , Deoxycholic Acid/pharmacology , Disease Progression , Humans , Immunohistochemistry , Microarray Analysis , Microscopy, Confocal , Microscopy, Electron, Transmission , RNA/biosynthesis , RNA/genetics , RNA, Small Interfering/pharmacology , Rats , Real-Time Polymerase Chain Reaction
2.
Clin Immunol ; 138(3): 321-30, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21256088

ABSTRACT

Calcineurin (CN) is a phosphatase that activates nuclear factor of activated T cells (NFAT). While the CN inhibitors cyclosporine A (CsA) and tacrolimus (FK506) can prevent graft rejection, they also cause inflammatory diseases. We investigated the role of calcineurin using mice deficient in the CN catalytic subunit Aß (CNAß). Cnab(-/-) mice exhibit defective thymocyte maturation, splenomegaly and hepatomegaly. Further, as Cnab(-/-) mice age, they exhibit spontaneous T-cell activation and enhanced production of proinflammatory cytokines (IL-4, IL-6, and IFNγ). FOXP3(+) T(reg) cells were significantly decreased in Cnab(-/-) mice likely contributing to increased T-cell activation. Interestingly, we found that CNAß is critical for promotion of BCL-2 expression in FOXP3(+) T(reg) and for permitting TGFß signaling, as TGFß induces FOXP3 in control but not in Cnab(-/-) T-cells. Together, these data suggest that CNAß is important for the production and maintenance of T(reg) cells and to ensure mature T-cell quiescence.


Subject(s)
Calcineurin/immunology , Homeostasis/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Calcineurin/genetics , Cytokines/biosynthesis , Cytokines/immunology , Forkhead Transcription Factors/immunology , Hepatomegaly/immunology , Hepatomegaly/metabolism , Lymphocyte Activation/immunology , Mice , Mice, Mutant Strains , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/immunology , Signal Transduction/immunology , Splenomegaly/immunology , Splenomegaly/metabolism , T-Lymphocytes, Regulatory/metabolism , Transforming Growth Factor beta/immunology
3.
Am J Physiol Gastrointest Liver Physiol ; 300(2): G292-302, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21127259

ABSTRACT

Barrett's esophagus (BE) is a premalignant condition, where normal squamous epithelium is replaced by intestinal epithelium. BE is associated with an increased risk of developing esophageal adenocarcinoma (EAC). However, the BE cell of origin is not clear. We hypothesize that BE tissue originates from esophageal squamous cells, which can differentiate to columnar cells as a result of repeated exposure to gastric acid and bile acids, two components of refluxate implicated in BE pathology. To test this hypothesis, we repeatedly exposed squamous esophageal HET1A cells to 0.2 mM bile acid (BA) cocktail at pH 5.5 and developed an HET1AR-resistant cell line. These cells are able to survive and proliferate after repeated 2-h treatments with BA at pH 5.5. HET1AR cells are resistant to acidification and express markers of columnar differentiation, villin, CDX2, and cytokeratin 8/18. HET1AR cells have increased amounts of reactive oxygen species, concomitant with a decreased level and activity of manganese superoxide dismutase compared with parental cells. Furthermore, HET1AR cells express proteins and activate signaling pathways associated with inflammation, cell survival, and tumorigenesis that are thought to contribute to BE and EAC development. These include STAT3, NF-κB, epidermal growth factor receptor (EGFR), cyclooxygenase-2, interleukin-6, phosphorylated mammalian target of rapamycin (p-mTOR), and Mcl-1. The expression of prosurvival and inflammatory proteins and resistance to cell death could be partially modified by inhibition of STAT3 signaling. In summary, our study shows that long-term exposure of squamous cells to BA at acidic pH causes the cells to display the same characteristics and markers as BE.


Subject(s)
Barrett Esophagus/etiology , Bile Acids and Salts/pharmacology , Esophagus/drug effects , Acids/pharmacology , Adenocarcinoma/metabolism , Biomarkers/metabolism , Cell Line, Transformed , Down-Regulation , Drug Resistance , Epithelium/metabolism , Esophageal Neoplasms/metabolism , Esophagus/cytology , Esophagus/metabolism , Humans , Hydrogen-Ion Concentration , Interleukin-6/metabolism , Metaplasia/metabolism , NF-kappa B/metabolism , Reactive Oxygen Species/metabolism , STAT3 Transcription Factor/antagonists & inhibitors , STAT3 Transcription Factor/metabolism , Signal Transduction , Superoxide Dismutase/metabolism , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...